Quidel | QDEL - Sales Revenues


Quidel reported $700M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Abbott USD 11.46B 90M Dec/2025
Agilent USD 1.86B 123M Sep/2025
Avanos Medical USD 177.8M 2.8M Sep/2025
Becton, Dickinson and Co. USD 5.9B 400M Sep/2025
Bruker USD 860.5M 63.1M Sep/2025
Charles River Laboratories USD 1000M 32.14M Sep/2025
Danaher USD 6.84B 790M Dec/2025
Exact Sciences USD 851M 39.9M Sep/2025
Haemonetics USD 338.97M 11.97M Dec/2025
Hologic USD 1.05B 0 Dec/2025
Illumina USD 1.16B 80M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Merit Medical Systems USD 384.2M 1.7M Sep/2025
Mettler Toledo International USD 1.13B 100M Dec/2025
Myriad Genetics USD 205.7M 7.4M Sep/2025
Neogen USD 224.69M 15.5M Sep/2025
Quidel USD 700M 86M Sep/2025
Revvity USD 772.06M 73.06M Dec/2025
STAAR Surgical USD 94.7M 50.4M Sep/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Waters USD 800M 29M Sep/2025